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Objective: To assess the feasibility of T2*-corrected fat-signal fraction (FF) map by using the three-echo volume 
interpolated breath-hold gradient echo (VIBE) Dixon sequence to differentiate between malignant marrow-replacing lesions 
and benign red marrow deposition of vertebrae.
Materials and Methods: We assessed 32 lesions from 32 patients who underwent magnetic resonance imaging after being 
referred for assessment of a known or possible vertebral marrow abnormality. The lesions were divided into 21 malignant 
marrow-replacing lesions and 11 benign red marrow depositions. Three sequences for the parameter measurements were 
obtained by using a 1.5-T MR imaging scanner as follows: three-echo VIBE Dixon sequence for FF; conventional T1-weighted 
imaging for the lesion-disc ratio (LDR); pre- and post-gadolinium enhanced fat-suppressed T1-weighted images for the 
contrast-enhancement ratio (CER). A region of interest was drawn for each lesion for parameter measurements. The areas 
under the curve (AUC) of the parameters and their sensitivities and specificities at the most ideal cutoff values from 
receiver operating characteristic curve analysis were obtained. AUC, sensitivity, and specificity were respectively compared 
between FF and CER.
Results: The AUCs of FF, LDR, and CER were 0.96, 0.80, and 0.72, respectively. In the comparison of diagnostic performance 
between the FF and CER, the FF showed a significantly larger AUC as compared to the CER (p = 0.030), although the 
difference of sensitivity (p = 0.157) and specificity (p = 0.157) were not significant.
Conclusion: Fat-signal fraction measurement using T2*-corrected three-echo VIBE Dixon sequence is feasible and has a 
more accurate diagnostic performance, than the CER, in distinguishing benign red marrow deposition from malignant bone 
marrow-replacing lesions.
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MATERIALS AND METHODS
Patients
The Institutional Review Board reviewed our study and 
issued a waiver. All patients signed an informed consent as 
part of their research hospital visits. From March 2012 to 
February 2013, 46 consecutive patients, who were referred 
for MR imaging to evaluate a suspected spinal malignancy (n 
= 32) or presented with an incidentally found marrow signal 
abnormality (defined as low or similar signal intensity to 
non-degenerated intervertebral disc on T1WI) during MR 
imaging, were assessed for the etiology of back or neck 
pain (n = 14). These patients underwent an MR protocol, 
including a FF mapping sequence, as described below. 
Patients, who received radiotherapy on the marrow lesions (n 
= 5) or systemic chemotherapy (n = 8) prior to MR imaging, 
were excluded because these treatments are known to 
cause unpredictable signal alterations that might affect FF 
(6). One patient was excluded because of an uncorrectable 
calculation error; this error, which was found during image 
analysis, presumably occurred during image acquisition of 
the FF mapping sequence. Therefore, our study included 32 
patients (17 women, 15 men; mean age, 59.9 ± 14.2 years; 
age range, 36–94 years) who underwent MR examination for 
naïve marrow lesions.
The subjects were divided into two groups; the division 
was based on the pathologic examination result or on 
the clinical and diagnostic imaging results, which were 
interpreted by two experienced musculoskeletal radiologists 
with 23 and 11 years of experience in spine imaging 
interpretation, respectively. 
Group 1 consisted of 21 subjects whose marrow lesions 
were malignant marrow-replacing lesions (9 women and 12 
men; mean age, 58 ± 12.8 years; age range, 36–94 years). 
These subjects were included in this group because of 
hot uptake of the lesion in 18F-fludeoxyglucose positron 
emission tomographic (PET)-computed tomography (CT) (n 
= 9), newly developed radiopharmaceutic uptake on follow-
up bone scintigraphy (n = 2), a pathologic result from CT-
guided biopsy (n = 8), and from bone marrow aspiration for 
patients with a suspected hematologic malignancy (n = 2). 
The malignant marrow-replacing lesions of the subjects were 
as follows: lung cancer (n = 4); pancreatic cancer (n = 1); 
colorectal cancer (n = 4); multiple myeloma (n = 2); thyroid 
carcinoma (n = 2); nasopharyngeal cancer (n = 1); gall 
bladder adenocarcinoma (n = 1); gastric adenocarcinoma 
(n = 1); breast cancer (n = 2); prostate cancer (n = 2); and 
INTRODUCTION
For physicians, one of the most commonly encountered 
scenarios during interpretation of conventional magnetic 
resonance (MR) imaging of the spine is differentiating 
neoplastic marrow infiltration from red marrow deposition 
(1). Several methods can be used for this differentiation, 
such as diffusion-weighted imaging, chemical-shift imaging, 
dynamic contrast-enhanced imaging, and MR spectroscopy 
(2, 3). In this study, we focused on chemical-shift imaging.
Normal marrow is an intermixture of hematopoietically 
active (red) marrow and inactive (yellow) marrow supported 
by varying proportions of structural trabecular bone. Red 
and yellow marrow possess a substantial fat component 
(2-5). Hence, benign red marrow deposition generally 
shows higher signal intensity (SI) on T1-weighted images 
as compared to sound muscle and the intervertebral disc 
(2, 3). On the other hand, the SIs of pathologic bone 
marrow lesions are generally similar to or lower than 
those of the muscle and disc because the fat-containing 
bone marrow of the spine is replaced by tumor cells (5-7). 
However, similar to pathologic bone marrow lesions, benign 
hypercellular red marrow may show an unexpectedly low 
SI on T1-weighted imaging (T1WI) (3). Many studies have 
tested in- and opposed-phase imaging for marrow lesion 
differentiation which is based on the expectation that the 
presence of fat in red marrow can cause the SI to drop on 
opposed-phase imaging (1, 5, 6, 8, 9). We thought that 
lesions without fat, which can be seen in marrow replacing 
conditions, could theoretically show no or less signal drop 
in the opposed phase. Hence, we commenced this study 
with the expectation that measurement of the fat-signal 
fraction (FF), considering T2* decay bias correction (10, 
11), could be feasible and may be more reasonable than an 
indirect measurement, with opposed-phase imaging, of fat 
within a lesion. To the best of our knowledge, the utility of 
FF quantification to differentiate between malignant and 
benign marrow lesions has not been addressed.
Hence, the purpose of this study was to evaluate the 
feasibility of T2*-corrected FF quantification by using three-
echo gradient echo imaging with T2* correction and Dixon 
water/fat separation to differentiate malignant marrow-
replacing lesions from benign red marrow deposition of 
vertebrae.
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hepatocellular carcinoma (n = 1).
Group 2 consisted of 11 subjects with benign red marrow 
depositions (3 women and 8 men; mean age, 63.6 ± 
16.5 years; age range, 38–90 years). These patients were 
included in this group based on histology (hypercellular 
red marrow, n = 4) and imaging assessment results (n = 
7). The imaging criteria included no size progression and 
morphologic change at 2-month and 6-month follow-up MRI 
(12, 13), no pathologic uptake with bone scan (n = 2) or 
PET/CT (n = 5). Other benign lesions were excluded, through 
CT, for all patients as follows: no coarse trabeculation to 
exclude hemangioma and no sclerosis to rule out lesion 
mineralization, which can be seen in benign notochordal 
cell tumor (14).
MR Imaging Protocol 
MR imaging was performed on a 1.5-T MR imaging 
scanner (MAGNETOM Avanto, Siemens Healthcare, Erlangen, 
Germany) with spine matrix coils. In addition to routine 
sequences including sagittal T1-weigthed turbo spin echo 
(TSE) imaging, fat-suppressed (FS) T1-weighted TSE images 
in the axial plane and pre- and post-gadolinium (Gd)-
enhanced FS T1-weighted TSE images (contrast material, 
0.1 mmol of gadoterate meglumine [Dotarem; Guerbet, 
Roissy, France] per kilogram of body weight) in the sagittal 
plane were included. For T2*-corrected FF quantification, 
a three-echo volume interpolated breath-hold gradient-
echo sequence (VIBE-Dixon, work-in-progress 432.rev.1, 
Siemens Healthcare, Erlangen, Germany) was used. It 
enables one to sample one opposed-phase echo and two in-
phase echoes. A T2* map is estimated from the latter two 
echoes; the opposed-phase and first in-phase echoes are 
then corrected for T2* effects, and they are processed by 
the two-point Dixon water/fat separation algorithm. This 
sequence automatically reconstructs FF images. The imaging 
parameters of the pulse sequences used for analysis are 
summarized in Table 1.
Image Analysis 
We obtained three parameters for one representative 
lesion (the largest lesion on the images), if multiple 
lesions were present, in each subject by using the images. 
The parameters were the FF, lesion-disc ratio (LDR), and 
contrast-enhancement ratio (CER). The FF was directly 
obtained by drawing a region of interest (ROI) of the 
lesion on the automatically reconstructed FF image 
obtained from the three-echo VIBE-Dixon sequence. The 
LDR was obtained from the following equation: LDR = 
(SI of marrow lesion/SI of disc) x 100, where SI was 
measured from the images obtained from sagittal T1WI. 
In a prior report, Zhao et al. (15) described that non-
degenerative disc and muscle showed similar accuracy as 
an internal standard to assess bone marrow pathologies 
in 1.5-T scanner images whereas muscle showed superior 
accuracy, as compared to non-degenerative disc, for the 
purpose in 3-T scanner images. Thus, in our study, the non-
degenerative disc SI was adopted as the internal reference 
standard to assess marrow lesions because we used a 1.5-
T MR imaging scanner. Additionally, on sagittal images, a 
non-degenerative disc was easier to select than non-fatty 
muscles. The degeneration of disc was evaluated by using 
Pfirrmann’s grading system (16). The CER was calculated 
by dividing the difference between the LDR values of post- 
and pre-Gd-enhanced FS T1WI by the LDR value of pre-Gd-
enhanced FS T1WI and according to the following equation: 
CER = (LDRpost Gd-enhanced FS T1WI - LDRpre Gd-enhanced FS T1WI) x 100/
Table 1. Summary of Analyzed MR Imaging Parameters 
Imaging Parameters
Sagittal T1-
Weighted TSE
Sagittal FS T1-
Weighted TSE
Sagittal Gd-Enhanced FS 
T1-Weighted TSE
Sagittal Three-Echo  
VIBE-Dixon
Repetition time (msec) 450 575 575 20
Echo time (msec) 10 10 10 4.76, 7.14, 9.52
Bandwidth (Hz/pixel) 199 199 199 558
Echo train length 3 3 3 1
Flip angle (°) 145 145 145 25
No. of slices 17 17 17 30
Section thickness, gap (mm) 3, 0.3 3, 0.3 3, 0.3 3, 0
Matrix size 410 × 512 410 × 512 410 × 512 192 × 256
Field of view (mm) 500 × 500 500 × 500 500 × 500 400 × 400
Imaging time 4 min, 30 sec 4 min, 50 sec 4 min, 50 sec 1 min, 10 sec
Note.— FS = fat suppressed, Gd = gadolinium, TSE = turbo spin echo, VIBE = volume interpolated breath-hold gradient echo
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LDRpre Gd-enhanced FS T1WI, where LDRpost Gd-enhanced FS T1WI and LDRpre 
Gd-enhanced FS T1WI are the LDR of the lesion on enhanced and 
unenhanced images, respectively. The SI of a tissue on an 
MR image is not an absolute value because it is determined 
by coil loading, the receiver setting at the MR console, 
and image reconstruction parameters; thus, the SI value 
must be related to an internal standard (17). We set the 
intervertebral disc, which does not generally enhance with 
Gd, as the internal standard to measure the enhancement 
degree on pre- and post-Gd-enhanced FS T1WI. 
To test whether the disc was enhanced, the signal-to-
noise ratio (SNR) of each reference disc was estimated by 
dividing the SI of the disc by the standard deviation of the 
background SI. For this calculation, a third-year resident 
trainee drew the ROIs both for pre- and post-Gd-enhanced 
FS T1WI at the identical location of the images by copying 
and pasting the ROIs on an MR imaging work station, as 
described below. The mean SNRs of the discs were compared 
between the sequences. We presumed that the disc was an 
appropriate internal standard. All three parameters were 
recorded as percentages.
A round ROI was drawn on an MR imaging workstation 
by using syngo MR software (VB17, Siemens Healthcare, 
Erlangen, Germany). The ROI for the representative lesion 
was drawn as large as possible without violating the 
adjacent marrow. The ROI for the non-degenerative disc 
(selected on the sagittal T2-weighted image) was drawn at 
the center of the nucleus pulposus, at the same image slice 
of the representative lesion; the ROI was drawn as large 
as possible and without violating the adjacent endplate. 
For the LDR and CER parameters, the ROI was drawn on the 
images from T1WI, and the ROI was copied and pasted on 
the corresponding images taken from pre- and post-Gd-
enhanced FS T1WI in order to obtain the measurement from 
the identical position for each lesion. However, the ROI for 
the FF was drawn at the most completely matched images 
and with reference to the T1WI because, given the different 
matrix and geometry parameters, it was impossible to copy 
and paste the ROI (Fig. 1). 
The average values of three consecutive slices in each 
target lesion were calculated and recorded. A third-
year resident trainee and a radiologist with 11 years of 
experience in musculoskeletal radiology independently drew 
the ROIs after the subject order was randomized.
Statistical Analysis
The interobserver agreement for measuring parameter 
values was assessed by using the intraclass correlation 
coefficient (ICC). The mean values of the parameters were 
used for further analyses. 
By using the paired Student’s t test, the mean SNRs of 
the reference discs were compared between the pre- and 
post-Gd-enhanced FS T1WI. In order to see if FF, LDR, and 
CER were affected by age and sex as previously reported (18), 
Spearman correlation coefficient and Mann-Whitney U test 
were conducted.
The median values and interquartile range of each group 
in each parameter were calculated for group 1 and 2. Since 
normality assumption was violated when we used the 
Shapiro-Wilk test (p < 0.05), we used nonparametric Mann-
Whitney U test to compare the median values of the three 
parameters between the two groups. 
Receiver operating characteristic (ROC) curves were 
obtained in order to evaluate the diagnostic performance 
of the three parameters while the sensitivities and 
specificities, at the most ideal cut-off values, were 
determined by the ROC curve. Confidence intervals for the 
area under the curve (AUC), sensitivity, and specificity 
were computed to account for sampling variation in the 
data. False-positive (erroneously defined as malignancy) 
and false-negative (erroneously defined as benign) results 
were counted for each parameter and were analyzed by two 
investigators in consensus regarding explanatory factors. 
For false-negative results, the pathology of the lesion was 
recorded. The usefulness of low signal intensity of the 
marrow lesions on T1WI as a tool for the differentiation 
between malignant and benign marrow lesions has well been 
validated in prior studies (19, 20), and we aimed to assess 
whether the FF quantification can be an additional tool for 
the differentiation by comparing it with CER. To compare 
the diagnostic performance of FF and CER, their AUCs were 
compared by using the DeLong test. The sensitivities and 
specificities of the two parameters were also compared by 
using McNemar’s test. 
All statistical analyses were performed by using SAS 
software (V 9.2, SAS Institute, Cary, NC, USA). P values < 
0.05 were considered statistically significant.
RESULTS
All overall interobserver agreements between the two 
readers for measuring parameter values indicated perfect 
agreement. The ICC values for FF, LDR, and CER were 0.991, 
0.997, and 0.965, respectively. The mean ROI size of the 
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readers was 90.0 ± 58.6 mm2 (range, 17.2–236.5 mm2) for 
lesions and 22.1 ± 19.7 mm2 (range, 5.7–53.2 mm2) for 
discs.
The Spearman correlation coefficient for the three 
paramaters and age were all below 0.3 with non-significant 
p value (> 0.05), indicating no correlation between age 
and the parameters. Also, the result of the Mann-Whitney U 
test showed that the median values of the three parameters 
were not significantly different between male and female. 
These results advocate that age and sex would not affect 
our analysis.
In the reference disc SNR enhancement assessment, the 
mean disc SNR of pre-Gd-enhanced FS T1WI was 44.6 ± 15.4 
(range, 15.5–72.0) and that of post-Gd-enhanced FS T1WI 
was 43.4 ± 16.0 (range, 15.1–72.2). No difference in the 
SNR was observed between pre- and post-Gd-enhanced FS 
T1WI (p = 0.168), indicating that the means discs were not 
enhanced and could be used as an internal standard.
The median values of each parameter in each group are 
summarized in Table 2. All three parameters showed a 
Fig. 1. Region of interest (ROI) placement and parameter measurement. Screen-captured image during ROI placement for parameter 
measurement of lesion and disc on workstation is shown. Images used for analysis were from fat-signal fraction (FF) mapping image from three-
point Dixon volume interpolated breath-hold gradient-echo sequence (top left), T1-weighted imaging (T1WI, top right), and pre- (bottom 
left) and post- (bottom right) gadolinium (Gd)-enhanced fat suppressed (FS) T1WI. Details regarding ROI placement are described in text. FF 
was obtained from FF mapping sequence image by directly placing ROI. Lesion-disc ratio (LDR) was obtained from image of T1WI. Contrast-
enhancement ratio (CER) was obtained from images of pre- and post-Gd-enhanced FS T1WI. Calculations for these parameters are described in 
text. Images of this capture were obtained from representative metastatic lesion from gastric cancer in 57-year-old man. FF, LDR, and CER were 
9.8%, 92.1%, and 157.6%, respectively. All parameters indicated that lesion was malignant.
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median difference between group 1 and 2 with statistical 
significance (Table 2). The AUC of each parameter, the 
optimal cut-off values obtained from the ROC curve, and 
the resultant sensitivity and specificity of each parameter 
are summarized in Table 3. In the analyses of false-
positive and false-negative results, FF showed three false-
negative results (metastases from prostate [n = 1], colon 
[n = 1], and breast cancer [n = 1]) (Fig. 2). LDR showed 
four false-positive results (one from pathologically proven 
hypercellular red marrow; three clinically categorized as red 
marrow deposition) (Fig. 3). CER showed two false-positive 
(both categorized as red marrow deposition clinically) (Fig. 
4) and seven false-negative results (metastases from rectal 
[n = 2], thyroid [n = 1], nasopharyngeal [n = 1], lung [n = 
1], prostate cancer [n = 1], and plasma cell myeloma [n = 1]) 
(Fig. 5).
In the comparison of AUCs between FF and CER, the 
AUC of FF was significantly higher as compared to that of 
CER (p = 0.030). In the McNemar’s test for the comparison 
of sensitivity and specificity between FF and CER, the 
difference of the sensitivity (p = 0.157), specificity (p = 
0.157) was not significant. 
DISCUSSION
We assessed whether FF obtained from vertebral body 
lesions is feasible in differentiating malignant marrow-
replacing lesions from benign red marrow deposition. We 
focused on red marrow deposition as the benign lesion. 
Although we used the chemical-shift imaging method 
utilized in the previous studies (4-7, 9, 21), we attempted 
to measure the FF itself, unlike these previous studies, as 
we thought this approach is more reasonable, as stated 
above. Regarding the use of marrow fat to differentiate 
between malignant versus benign bone marrow lesions, 
previous investigators focused on “signal drop” on opposed-
phase imaging because they postulated the coexistence 
of fat and water in marrow (4-7, 9, 21), which is possible 
when bone marrow is not completely replaced by space-
occupying lesions, would cause a signal drop in opposed-
phase imaging. These investigators measured the signal 
drop of opposed-phase imaging and suggested variable 
cut-off values to differentiate between various benign 
and malignant vertebral lesions (Table 4). With these 
parameters, the sensitivity and specificity of differentiating 
between benign and malignant lesion were 88.8–95% 
and 80.4–100%, respectively (4-7, 9, 21). The sensitivity 
(85.7%) and specificity (100%) of FF in our study were 
comparable to those of previous studies that utilized 
chemical-shift imaging, indicating that our study did not 
show improvement in diagnostic performance of chemical-
shift imaging as compared with previous studies. However, 
we believe our results unveiled the feasibility of FF as a 
tool for differentiation between benign and malignant focal 
bone marrow lesions, and further investigation with a larger 
study population is needed.
A high FF erroneously indicated that three lesions were 
benign: two sclerotic metastases from prostate or breast 
cancer and one from metastatic colon cancer. Zajick et al. (4)
reported that some metastatic lesions showed a large signal 
drop on opposed-phase imaging, mimicking benign bone 
lesions. They attributed the variability of metastatic lesions 
Table 2. Comparison of Median Values for Parameters between 
Malignant Marrow-Replacing Lesion and Benign Red Marrow 
Deposition Groups 
Parameter Median (IQR) P*
FF < 0.001
Group 1 12.8 (10.6–16.3)
Group 2 37.3 (26.0–48.0)
LDR 0.004
Group 1 91 (83.1–103.3)
Group 2 120 (101.0–133.9)
CER 0.038
Group 1 99.4 (87.9–110.2)
Group 2 64 (55.6–93.7)
Note.— *Statistical significance in difference of median values 
between group 1 and group 2 for each parameter. Group 1 = 
malignant marrow-replacing lesion, Group 2 = benign red marrow 
deposition. CER = contrast-enhancement ratio, FF = fat-signal 
fraction, IQR = interquartile range, LDR = lesion-disc ratio 
Table 3. Diagnostic Performance of Each Parameter Determined through Receiver Operating Characteristic Curve Analysis 
Parameter AUC Cutoff Values (%)* Sensitivity (%) Specificity (%) P†
FF 0.961 (0.826–0.998) ≤ 16.8% 85.7 (18/21; 63.7–97.0) 100 (11/11; 71.5–100) < 0.001
LDR 0.805 (0.627–0.923) ≤ 114.8% 100 (21/21; 83.9–100) 63.6 (7/11; 30.8–89.1)  0.002
CER 0.727 (0.542–0.869) > 93.7% 66.7 (14/21; 43.0–85.4) 81.8 (9/11; 48.2–97.7)  0.038
Note.— Numbers in parentheses in AUC column are 95% confidence intervals. Numbers in parenthesis in sensitivity and specificity 
columns are counts used for calculation and 95% confidence intervals. *Lesions were considered malignant when FF was 16.8% or less, 
LDR was 114.8% or less, and CER was 93.7% or greater, †P value of AUC. AUC = area under receiver operating characteristic curve, CER = 
contrast-enhancement ratio, FF = fat-signal fraction, LDR = lesion-disc ratio
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Fig. 2. Example of false-negative result (erroneously defined as benign) of fat-signal fraction (FF) illustrated from MR images 
and computed tomography (CT) image obtained from 54-year-old man. 
He was referred for assessment of metastatic bone lesion of 4th lumbar (L4) vertebra from prostate cancer, which was suspected on bone 
scintigraphy by newly developed radiopharmaceutical uptake. Images obtained from MR imaging (FF mapping sequence (A), T1-weighted imaging 
(T1WI) (B), post-gadolinium-enhanced fat suppressed T1WI (C)), and non-contrast CT image (D) of L4 vertebral body are shown. FF image 
revealed high FF of lesion (arrow in A), which indicated considerable amount of fat. Lesion showed low signal intensity on T1WI (arrow in B), 
and it did not show avid enhancement (arrow in C). Because lesion newly developed during follow-up and appeared to be space-occupying lesion 
rather than degenerative change or osteitis related to enthesitis, it was categorized as group 1 (malignant marrow-replacing lesion) and was 
considered metastatic bone lesion from prostate cancer. FF, lesion-disc ratio (LDR), and contrast-enhancement ratio (CER) were calculated as 
28.1%, 36.7%, and 49.5%, respectively, which shows that FF and CER erroneously indicated lesion was benign (false-negative results), whereas 
LDR correctly indicated lesion was malignant (true-positive result). Axial non-contrast CT image (D) revealed osteoblastic characteristics of this 
metastatic lesion.
A CB D
Fig. 3. Example of false-positive result (erroneously defined as malignant) of lesion-disc ratio (LDR) illustrated from MR images 
obtained from 46-year-old woman. 
She was referred for assessment of cause of back pain, and she was incidentally found to have marrow lesion of 2nd thoracic (T2) vertebra. 
Images obtained from fat-signal fraction (FF) mapping sequence (A), T1-weighted imaging (T1WI) (B), and post-gadolinium-enhanced fat 
suppressed T1WI (C) are shown. FF image revealed high FF of lesion (arrow in A), which indicated considerable amount of fat. Lesion showed 
low signal intensity on T1WI (arrow in B), and it did not show avid enhancement (arrow in C). Lesion almost completely replaced T2 vertebral 
body, and region of interest was drawn as described in text. CT-guide biopsy revealed that lesion was hypercellular red marrow (80% cellularity) 
without evidence of malignancy; hence, lesion was categorized as group 2 (benign red marrow deposition). FF, LDR, and contrast-enhancement 
ratio (CER) were calculated as 39.8%, 88.9%, and 81.5%, respectively, which shows that FF and CER correctly indicated lesion was benign (true-
negative result), whereas LDR erroneously indicated lesion was malignant (false-positive result).
A B C
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Fig. 5. Example of false-negative result (erroneously defined as benign) of contrast-enhancement ratio (CER) illustrated from MR 
images obtained from 42-year-old man. 
He was referred for assessment of metastasis at vertebral column, which was suspected on 18F-fludeoxyglucose (FDG) positron-emission 
tomographic (PET)-computed tomography (CT). Images obtained from fat-signal fraction (FF) mapping sequence (A), T1-weighted imaging 
(T1WI) (B), and post-gadolinium-enhanced fat suppressed T1WI (C) of T9 vertebral body. FF image revealed low FF of lesion (arrow in A), 
which indicated low amount of fat. Lesion showed low signal intensity on T1WI (arrow in B), and it did not show avid enhancement (arrow in 
C). Because 18F-FDG PET-CT of this patient showed multiple increased FDG uptakes of skeleton and lung, T9 vertebral lesion was categorized as 
group 1 (malignant marrow-replacing lesion). Lesion almost completely replaced vertebral body, and region of interest was drawn as described in 
text. FF, lesion-disc ratio (LDR), and CER were calculated as 12.8%, 82.5%, and 51.6%, respectively, which shows that CER erroneously indicated 
lesion was benign (false-negative result), whereas FF and LDR correctly indicated lesion was malignant (true-positive result).
A B C
Fig. 4. Example of false-positive result (erroneously defined as malignant) of contrast-enhancement ratio (CER) illustrated from 
MR images obtained from 66-year-old woman. 
She was referred for assessment of cause of back pain, and she was incidentally found to have marrow lesion of 5th lumbar (L5) vertebra. Images 
obtained from fat-signal fraction (FF) mapping sequence (A), T1-weighted imaging (T1WI) (B), and post-gadolinium-enhanced fat suppressed 
T1WI (C) of L5 vertebral body are shown. FF image showed focal lesion (arrow in A). Multifocal high FF of lesion (arrowheads in A) was observed, 
which indicated multifocal fat depostion. Lesion showed low signal intensity on T1WI (arrow in B), and it had relatively avid enhancement (arrow 
in C). Because lesion did not show morphologic or signal change on 6-month follow-up MR imaging and did not show mineralization or osteolytic 
lesion at corresponding area on CT scan (D), lesion was categorized as group 2 (benign red marrow deposition). FF, lesion-disc ratio (LDR), and 
CER were calculated as 26.0%, 101.8%, and 132.4%, respectively, which shows that LDR and CER erroneously indicated lesion was malignant 
(false-positive result), whereas FF correctly indicated lesion was benign (true-negative result).
A CB D
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from lytic to sclerotic states, with sclerotic lesions having 
lower SIs (4). Although Zajick et al. did not completely 
explain the reason for this observation, we believe that the 
two sclerotic lesions showing false-negative results in our 
study are consistent with it. We adopted three-echo Dixon 
integrated into the VIBE sequence. The Dixon technique 
is a well-established imaging sequence for discrimination 
between water and fat protons and is based on their 
resonant frequency difference (22). Three-echo Dixon 
technique has been developed to correct T2* decay due 
to intra-voxel static field inhomogeneity, which depends 
on tissue structure and chemical properties. Three-echo 
Dixon has been proven to provide highly reproducible and 
accurate results in fat quantification (23) as compared with 
two-echo Dixon without T2* correction.
Even with correction of T2* effects, FF quantification 
may be confounded by other effects, like the multi-spectral 
nature of fat (24). As a result, the three-echo VIBE-Dixon 
sequence may produce errors similar to those observed in 
previous studies that utilized other chemical-shift imaging 
techniques, and this topic should be investigated further. 
However, we have no plausible explanation for the false-
negative result for colon cancer metastasis in our study.
Hypothetically, the FF values for malignant marrow-
replacing lesions should be near 0% because the lesion 
replaces bone marrow. However, the FF cut-off value for 
differentiation between malignant marrow-replacing lesions 
and benign red marrow deposition was unexpectedly high 
in our study (16.8%). Although many previous studies 
assessed the liver rather than bone marrow, it is known that 
the T1 and T2* effects should be minimized to measure 
FF accurately because all MR signals are subject to T1 and 
T2/T2* relaxation (11). We believe the T2* effect was 
minimized in our study because we adopted a sequence 
that corrects the effect of T2* decay, by using signals at 
three different echo times, which was validated in a prior 
report (10). However, the 25° flip angle used in our study 
might have produced the T1 effect, which is known to 
cause FF overestimation. Cassidy et al. (11) recommended 
a flip angle of 5–10° and a repetition time of ≤ 100 msec 
to minimize the T1 effect for liver fat quantification; 
the sequence parameters that minimize the T1 effect for 
bone marrow might be different from these parameters, 
but we could not find any related references. Hence, 
we optimized our sequence empirically, and we could 
not minimize the flip angle to < 25°, which would have 
assured an appropriate image quality with respect to the 
SNR at the commencement of our study. We believe 25° 
Table 4. Summary of Previous Studies Related to Chemical-Shift Imaging for Differentiation between Benign and Malignant 
Lesions
Study
Total Number of 
Patients (Lesions)*
Lesions That Were Differentiated† Parameter
Suggested  
Cut-Off Value‡
Sensitivity Specificity
Disler  
  et al. (9)
30 patients (31)
Non-neoplastic lesion (14)
Neoplastic lesion (17)
SI ratio (SIopposed-phase/SIin-phase) > 0.81 95% 95%
Zampa  
  et al. (7)
86 patients (86)
Benign lesion (41) 
Malignant lesion (45)
SI ratio (SIopposed-phase/SIT1WI) > 1.2 88.8% 80.4%
Eito  
  et al. (21)
108 patients (190)
Normal vertebrae (90)
Compression fracture (100)
Non-neoplastic (73)
Neoplastic (27)
SI ratio (SIopposed-phase/SIin-phase) None§ N/A N/A
Zajick  
  et al. (4)
75 patients (569)
92 patients (215)
Normal vertebrae (569)
Benign lesion (164) 
Malignant lesion (51)
% decrease of SIopposed-phase 
compared with SIin-phase
≤ 20% N/A N/A
Erly  
  et al. (6)
21 patients (49)
Benign compression fracture (29)
Malignant lesion (20) 
SI ratio (SIopposed-phase/SIin-phase) > 0.8 95% 89%
Ragab  
  et al. (5)
40 patients (40)
Compression fracture (40)
Osteoporotic (20)
Neoplastic (20)
% decrease of SIopposed-phase 
compared with SIin-phase
≤ 35% 95% 100%
Note.— *Numbers in parentheses in this column are counts of lesions, †Normal, benign, and malignant lesions that were described 
and assessed. Numbers in parentheses of this column are counts of lesions, ‡Lesions were defined as malignant when suggested cut-
off value was satisfied for each parameter, §Eito et al. calculated mean value of each lesion group, but did not estimate cut-off value 
for differentiating between groups. N/A = not available, SI = signal intensity, SIin-phase = signal intensity of in-phase image, SIopposed-phase = 
signal intensity of opposed-phase image, SIT1WI = signal intensity of T1-weighted image
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was not adequate for minimizing the T1 effect, given the 
unexpectedly high FF of our study. Further validation of 
FF quantification sequences is needed. T1 effect reduction 
could be achieved by using a more accurate correction of 
the confounding T2* effect and multi-spectral fat nature, by 
using signals from more echo time points, and using a low 
flip angle.
The sensitivity and specificity of T1WI in previous studies 
that were performed with 1.5-T scanners were 62.5–100% 
and 92–93.8% for differentiating benign and malignant 
lesions, respectively (15, 20). Although the sensitivity of 
our study was comparable to that of these studies, the 
specificity was far lower due to different analysis methods 
(20) and the selection of benign subjects for comparison 
(15). Nevertheless, LDR is a sensitive method in daily 
practice for detection or screening of marrow signal 
abnormality, and we do not believe that our study supports 
that FF can replace LDR in that regard. Rather, we expect 
that the FF would play a complementary role for additional 
differentiation with its high specificity, which would be 
superior to CER, since CER showed poorer performance 
when compared to FF in our study. Gd-enhanced MR 
imaging needed to be compared with the FF measurement 
in the performance of differentiation between benign and 
malignant marrow lesions because previous studies have 
already elucidated its usefulness in this aspect (13, 25, 26).
Our study had several limitations. First, the small number 
of study subjects might have biased our results. Second, 
the pulse sequence for FF quantification was not validated 
through a bone marrow phantom because this is technically 
difficult. However, we have elucidated that a T2*-corrected 
FF map by using the three-echo VIBE-Dixon sequence, 
which is at least feasible for differentiating between 
malignant marrow-replacing lesions and benign red marrow 
deposition of vertebrae. Third, not all assessed lesions 
were pathologically proven because it would be unethical 
to biopsy lesions with a high probability of malignancy 
or benignancy in a clinical setting. Fourth, we adopted 
only LDR for the parameters on T1WI, although qualitative 
assessment of imaging findings (e.g., bull’s eye sign) 
(27) is useful for differentiating between malignant and 
benign bone lesions. This reason may also explain why the 
specificity of T1WI was lower than expected in our study. 
However, this qualitative assessment was beyond the scope 
of our study.
In conclusion, T2*-corrected FF measurement using a 
three-echo VIBE-Dixon sequence is feasible and is expected 
to play a complementary role for distinguishing benign red 
marrow deposition from malignant bone marrow-replacing 
lesions of vertebrae.
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